Risk & Weakness
Bankruptcy Study: Stacked Warning Signals
138 Findings · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits
Methodology & criteria
The working version of our own analysis of 792 U.S. bankruptcies since 2005. Its core finding: no single warning sign carries a verdict — even the sharpest one is wrong in more than 95 out of 100 cases. Only accumulation matters. With no signal active, 0.18 percent of companies filed for bankruptcy within twelve months; with six active at once, 3.16 percent did. This scanner counts how many of the study's warning signals are burning at the same time and lists companies with at least three. Counted are the filings with the securities regulator over the past twelve months — exchange notice, late annual or quarterly report, change of auditor, non-reliance on previously issued figures, accelerated credit facility, going-concern doubt — plus the balance-sheet signals: Altman Z″ in the distress zone (below 1.1), interest not earned, operating cash flow negative over four quarters, cash lasting less than four quarters, equity wiped out, current liabilities exceeding current assets. At least one regulatory filing must be among them: a purely balance-sheet stack otherwise catches large buyback-heavy corporations that are no bankruptcy candidates at all. Banks and financial services are excluded because their cash flow swings by design. Important: a hit is a cluster of warning signals, not a bankruptcy verdict — four out of five of these companies survive the year. Source: fundamental data.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTX Syntec Optics Holdings Inc. | — | -28 % | ⚠ Wildest 10% 139 % | Stage 2 | D 31 | 4 of 9 | 0.3 $ | Electronic Components | – | — | — | Technology | 6.70 $ | +289.2 % | +326.6 % | +279.7 % | −34.3 % | — | 99 | 13 | 12.3 % | 15.1 % | -0.76 | — | 0.0 | 9.3 | — | — | — | 254.5 | — | 19.6 % | -8.3 % | -30.0 % | -2.6 % | — | — | -4.6 % | 3 | 0.0 % | 0.0 % | 5.1 | 3.5 % | 21.4 % | — |
| KOD Kodiak Sciences Inc | 08/12 | +137 % | ⚠ Wildest 10% 109 % | Stage 2 | D 28 | 2 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 32.90 $ | +32.5 % | +21.4 % | +256.7 % | −28.7 % | +111.6 % | 98 | 42 | 8.0 % | 7.7 % | 2.18 | — | 0.0 | — | — | — | — | -0.1 | 0.0 % | — | 0.0 % | -208.8 % | -60.5 % | — | 36.6 % | — | 3 | 0.0 % | 0.0 % | -15.7 | 99.6 % | 27.2 % | 2.8 (6) |
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | ⚠ Wildest 10% 164 % | Stage 3 | D 33 | 4 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.681 $ | +7.6 % | -7.7 % | -33.2 % | −52.5 % | +642.4 % | 97 | 42 | 16.8 % | 20.7 % | 0.75 | — | 2.8 | — | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -143.2 % | — | — | +730.9 % | 3 | 0.0 % | 0.0 % | -116.1 | 6.9 % | 14.4 % | 4.5 (6) | |
| APGE Apogee Therapeutics, Inc. | 08/10 | — | 63 % | Stage 2 | D 37 | 4 of 9 | 10.1 $ | Biotechnology | – | — | — | Healthcare | 135.10 $ | +76.0 % | +69.8 % | +254.0 % | −0.4 % | -0.4 % | 96 | 42 | 6.7 % | 6.5 % | 0.33 | — | 0.0 | — | 8.1 | — | — | 0.0 | 0.0 % | — | 0.0 % | -28.5 % | -20.3 % | 0.01 | 97.1 % | — | 3 | 0.0 % | 0.0 % | 40.3 | 131.6 % | 7.3 % | 5.0 (9) |
| FIRY FIRY | 08/06 | -24 % | ⚠ Wildest 10% 162 % | Stage 2 | D 40 | 4 of 9 | 0.2 $ | Electronic Gaming & Multimedia | Sells AI | — | Communication Services | 10.30 $ | +111.6 % | -36.1 % | +42.3 % | −58.2 % | -11.0 % | 95 | 42 | 11.2 % | 11.7 % | 4.61 | — | 0.0 | 1.4 | 1.5 | — | — | -0.2 | — | 87.8 % | -60.2 % | -49.6 % | -14.6 % | 1.26 | — | -31.3 % | 4 | 0.0 % | 0.0 % | -9.1 | 37.8 % | 21.9 % | — | |
| QMCO Quantum Corporation | — | -32 % | ⚠ Wildest 10% 113 % | Stage 2 | D 37 | 4 of 9 | 0.8 $ | Computer Hardware | Uses AI | — | Technology | 24.90 $ | +114.1 % | +60.8 % | +198.7 % | −30.0 % | +5.3 % | 94 | 42 | 14.0 % | 14.5 % | 3.15 | — | 1.9 | 2.6 | 0.2 | — | 0.77 | 236.9 | — | 37.8 % | -80.8 % | 0.0 % | -0.4 % | -0.04 | — | -12.1 % | 1 | 0.0 % | 0.0 % | -26.0 | 12.8 % | 4.7 % | 3.0 (2) | |
| CORZ Core Scientific, Inc. | 08/14 | — | 71 % | Stage 2 | C 45 | 4 of 9 | 5.4 $ | Software - Infrastructure | – | — | — | Technology | 17.10 $ | +100.3 % | +66.6 % | +5.4 % | −10.5 % | +117.1 % | 93 | 80 | 6.3 % | 6.5 % | 5.49 | — | 27.2 | 12.3 | 0.0 | — | — | 454.9 | -18.8 % | 32.1 % | 0.0 % | 0.0 % | -2.4 % | -1.57 | -42.5 % | -37.5 % | 4 | 0.0 % | 0.0 % | -5.1 | 124.5 % | 22.8 % | 4.7 (16) |
| AOSL Alpha and Omega Semiconductor Ltd | 08/05 | +17 % | ⚠ Wildest 10% 91 % | Stage 2 | C 54 | 4 of 9 | 0.8 $ | Semiconductors | – | — | — | Technology | 25.20 $ | +127.5 % | +123.7 % | -10.3 % | −15.9 % | +73.6 % | 93 | 2 | 10.2 % | 11.0 % | 2.56 | — | 8.3 | 1.2 | 0.9 | — | — | 26.6 | — | 22.3 % | -6.2 % | -12.6 % | -2.7 % | 0.04 | — | +5.9 % | 3 | 0.0 % | 0.0 % | 11.6 | 75.1 % | 12.2 % | 3.7 (3) |
| REPL Replimune Group Inc | 07/02 | -31 % | ⚠ Wildest 10% 194 % | Stage 3 | D 43 | 1 of 9 | 1.1 $ | Biotechnology | Neutral | — | Healthcare | 12.90 $ | +17.5 % | -40.2 % | +125.4 % | −15.9 % | +51.2 % | 92 | 42 | 9.2 % | 10.0 % | 0.94 | — | 0.0 | — | 5.4 | — | — | -0.2 | — | — | 0.0 % | -90.9 % | -51.3 % | 0.36 | — | — | 2 | 0.0 % | 0.0 % | -8.4 | 96.9 % | 40.8 % | 4.4 (8) | |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | ⚠ Wildest 10% 130 % | Stage 1 | D 35 | 4 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 4.10 $ | +11.6 % | +0.8 % | +38.5 % | −60.2 % | +326.8 % | 91 | 42 | 11.0 % | 10.5 % | 1.35 | — | 0.0 | — | — | — | — | 14.4 | — | -217.4 % | 0.0 % | -3,439.4 % | -25.8 % | — | — | -5.2 % | 3 | 0.0 % | 0.0 % | -52.2 | 10.5 % | 7.9 % | 4.0 (1) |
| SPIR Spire Global Inc | 08/12 | +124 % | ⚠ Wildest 10% 103 % | Stage 2 | C 48 | 4 of 9 | 0.5 $ | Specialty Business Services | Sells AI | — | — | Industrials | 12.10 $ | +132.5 % | +114.7 % | +21.3 % | −38.3 % | +80.0 % | 90 | 42 | 9.1 % | 11.1 % | 2.58 | 7.5 | 0.0 | 7.7 | 5.3 | — | — | 7.8 | — | 37.9 % | -145.2 % | 101.2 % | -22.0 % | 0.13 | — | -35.2 % | 4 | 0.0 % | 0.0 % | -8.1 | 39.9 % | 10.0 % | 4.6 (5) |
| KPTI Karyopharm Therapeutics Inc | 08/10 | -23 % | ⚠ Wildest 10% 157 % | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | Uses AI | — | — | Healthcare | 1.80 $ | +31.1 % | +35.0 % | -70.6 % | −13.9 % | +326.5 % | 89 | 42 | 7.7 % | 8.7 % | 0.96 | — | 0.0 | 0.3 | 2.4 | — | — | -1.9 | — | 13.4 % | -153.3 % | -891.1 % | -47.6 % | -0.87 | — | +0.6 % | 3 | 0.0 % | 0.0 % | -48.8 | 83.7 % | 43.5 % | 4.4 (7) |
| ECOR Electrocore LLC | 08/05 | +35 % | 85 % | Stage 2 | C 52 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 11.40 $ | +86.2 % | +66.4 % | +131.5 % | −31.5 % | +79.2 % | 87 | 42 | 11.0 % | 11.5 % | 1.01 | — | 384.6 | 2.7 | 59.3 | — | — | 0.2 | — | 87.1 % | -40.0 % | -478.7 % | -55.0 % | -1.67 | — | +27.2 % | 6 | 0.0 % | 0.0 % | -44.7 | 9.2 % | 3.8 % | 4.6 (5) |
| ORMP Oramed Pharmaceuticals Inc | 08/13 | +13 % | 55 % | Stage 2 | C 53 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 4.70 $ | +56.9 % | +58.0 % | +120.7 % | −3.7 % | +52.2 % | 87 | 75 | 7.3 % | 6.4 % | 1.19 | 1.8 | 0.0 | — | 0.8 | — | — | 1.9 | — | — | 0.0 % | 58.2 % | -3.4 % | 0.00 | — | -100.0 % | 4 | 5.4 % | 11.4 % | 13.8 | 37.1 % | 3.3 % | 3.0 (1) |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | ⚠ Wildest 10% 124 % | Stage 3 | D 31 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 2.10 $ | +248.7 % | +177.9 % | -14.0 % | −33.6 % | +302.0 % | 86 | 42 | 10.2 % | 9.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -58.4 % | — | — | — | 2 | 0.0 % | 0.0 % | -16.0 | 15.0 % | 12.7 % | 4.0 (2) | |
| HLIT Harmonic Inc | 07/27 | -4 % | 51 % | Stage 2 | C 50 | 4 of 9 | 1.2 $ | Communication Equipment | Threatened | — | Technology | 11.00 $ | +48.2 % | +58.1 % | +9.6 % | −31.5 % | +46.8 % | 86 | 72 | 4.9 % | 6.8 % | 1.32 | 138.6 | 18.8 | 2.4 | 3.5 | 918.5 | 1.84 | 18.6 | 16.8 % | 50.0 % | -10.6 % | 2.1 % | 4.7 % | 0.31 | 53.3 % | -46.9 % | 4 | 0.0 % | 0.0 % | -0.8 | 89.0 % | 7.5 % | 3.6 (7) | |
| ADV Advantage Solutions Inc | 08/06 | -10 % | ⚠ Wildest 10% 96 % | Stage 2 | D 35 | 4 of 9 | 0.4 $ | Advertising Agencies | – | — | — | Communication Services | 33.00 $ | +81.0 % | +112.3 % | -29.0 % | −10.0 % | +27.7 % | 86 | 29 | 9.4 % | 8.9 % | 2.11 | — | 0.0 | 0.1 | 0.9 | 6.7 | — | 27.6 | — | 13.5 % | -7.6 % | -41.5 % | 2.3 % | 3.24 | — | -0.7 % | 5 | 0.0 % | 0.0 % | 0.4 | 30.8 % | 11.9 % | 3.7 (3) |
| BZFD BuzzFeed Inc | 08/06 | -20 % | ⚠ Wildest 10% 106 % | Stage 3 | D 26 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 1.10 $ | +64.5 % | -12.4 % | -40.5 % | −50.0 % | -9.1 % | 86 | 13 | 10.5 % | 12.3 % | 3.79 | — | 172.4 | 0.5 | — | — | — | -7.7 | — | 39.8 % | -35.8 % | -90.2 % | -7.8 % | — | — | -2.4 % | 2 | 0.0 % | 0.0 % | -12.8 | 10.0 % | 4.4 % | 5.0 (1) |
| ATRA Atara Biotherapeutics Inc | 08/10 | -29 % | ⚠ Wildest 10% 143 % | Stage 3 | D 31 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 9.70 $ | -38.3 % | -67.1 % | -16.2 % | −46.6 % | +35.3 % | 85 | 42 | 8.3 % | 8.3 % | 0.11 | — | 17.5 | 14.2 | 15.5 | — | — | 2.2 | — | 75.3 % | -269.4 % | -2,014.9 % | -24.1 % | -0.27 | — | -6.3 % | 7 | 0.0 % | 0.0 % | -327.5 | 52.5 % | 5.8 % | 4.6 (5) |
| XRX Xerox Corp | 07/30 | -24 % | ⚠ Wildest 10% 88 % | Stage 3 | C 46 | 4 of 9 | 0.5 $ | Business Equipment & Supplies | Sells AI | — | Industrials | 3.60 $ | +35.1 % | +31.2 % | +3.1 % | −52.7 % | +9.0 % | 83 | 64 | 7.0 % | 9.3 % | 2.46 | — | 2.6 | 0.1 | — | 1.6 | 0.20 | 12.3 | — | 30.6 % | -11.9 % | -115.4 % | 1.0 % | — | — | +12.9 % | 4 | 2.9 % | 3.3 % | 4.3 | 69.9 % | 35.5 % | 2.8 (5) | |
| ACHV Achieve Life Sciences Inc | 08/06 | -5 % | ⚠ Wildest 10% 88 % | Stage 2 | D 26 | 3 of 9 | 0.8 $ | Biotechnology | – | — | — | Healthcare | 7.90 $ | +0.8 % | +39.7 % | +167.2 % | −7.5 % | +92.1 % | 79 | 42 | 8.7 % | 8.2 % | 2.25 | — | 35.3 | — | — | — | 17.68 | -2.4 | — | — | 0.0 % | -496.2 % | -29.2 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -29.4 | 61.0 % | 16.1 % | 4.9 (8) |
| PYXS Pyxis Oncology Inc | 08/13 | -7 % | ⚠ Wildest 10% 136 % | Stage 3 | D 41 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.40 $ | +82.6 % | +157.7 % | +54.3 % | −59.8 % | +155.9 % | 79 | 42 | 12.6 % | 11.3 % | 1.34 | — | 0.0 | — | 6.7 | — | — | 1.1 | — | 78.4 % | 0.0 % | -121.7 % | -62.9 % | 0.58 | — | -14.2 % | 4 | 0.0 % | 0.0 % | -24.8 | 33.9 % | 5.9 % | 4.4 (7) |
| RDZN Roadzen Inc. | — | -31 % | ⚠ Wildest 10% 91 % | Stage 1 | D 43 | 4 of 9 | 0.1 $ | Software - Application | Sells AI | — | — | Technology | 1.20 $ | -36.1 % | -24.9 % | +26.3 % | −43.4 % | +316.7 % | 79 | 42 | 9.6 % | 8.4 % | 1.25 | — | 0.0 | 1.7 | — | — | — | -4.4 | — | 60.7 % | -46.9 % | 0.0 % | -18.9 % | — | — | -5.2 % | 5 | 0.0 % | 0.0 % | -20.2 | 3.0 % | 3.6 % | 4.5 (2) |
| UAMY United States Antimony Corporation | 08/11 | +720 % | ⚠ Wildest 10% 132 % | Stage 4 | D 39 | 1 of 9 | 0.7 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 4.60 $ | +39.6 % | +9.6 % | -17.7 % | −65.2 % | +122.1 % | 78 | 50 | 8.1 % | 8.7 % | 0.40 | — | 476.2 | 18.7 | 6.3 | — | — | 9.3 | — | 17.4 % | -44.6 % | -19.7 % | -12.5 % | 0.00 | — | +162.8 % | 6 | 0.0 % | 0.0 % | 11.2 | 57.4 % | 23.1 % | 4.8 (4) |
| ABOS Acumen Pharmaceuticals Inc | 08/11 | -19 % | 83 % | Stage 2 | D 36 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | +14.2 % | +28.2 % | +105.6 % | −38.6 % | +184.6 % | 78 | 42 | 7.9 % | 6.8 % | 0.38 | — | 0.0 | — | 2.2 | — | — | -0.6 | — | -26,379.0 % | 0.0 % | -93.2 % | -45.8 % | 0.36 | — | -100.0 % | 2 | 0.0 % | 0.0 % | -6.5 | 64.2 % | 6.3 % | 5.0 (5) |
| LASE Laser Photonics Corporation | 08/21 | -32 % | ⚠ Wildest 10% 171 % | Stage 3 | E 23 | 2 of 9 | 0.0 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 0.8875 $ | — | — | -68.3 % | −71.3 % | — | 77 | 3 | 16.3 % | 17.9 % | 2.44 | — | 0.0 | 7.2 | 4.6 | — | — | 28.8 | -303.2 % | -16.8 % | 0.0 % | -727.4 % | -57.7 % | — | -53.3 % | +132.0 % | 4 | 0.0 % | 0.0 % | -4.9 | 12.0 % | 11.5 % | 5.0 (1) | |
| LTRN Lantern Pharma Inc | 08/12 | -8 % | ⚠ Wildest 10% 105 % | Stage 3 | D 27 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 1.70 $ | +26.4 % | +21.9 % | -56.3 % | −36.1 % | +821.1 % | 77 | 42 | 8.4 % | 10.3 % | 2.30 | — | 0.0 | — | 6.6 | — | — | 0.2 | — | — | 0.0 % | -157.4 % | -74.3 % | 0.02 | — | — | 3 | 0.0 % | 0.0 % | -51.2 | 14.2 % | 4.4 % | 5.0 (2) |
| AMC AMC Entertainment Holdings Inc | 08/10 | -32 % | 82 % | Stage 3 | D 43 | 3 of 9 | 2.7 $ | Entertainment | Uses AI | — | Communication Services | 2.70 $ | +33.3 % | +20.8 % | -3.9 % | −47.5 % | +6.8 % | 76 | 42 | 15.0 % | 12.2 % | 2.21 | — | 122.0 | 0.5 | — | 117.9 | 12.22 | 28.6 | — | 18.2 % | -10.6 % | 0.0 % | 2.1 % | — | — | +4.6 % | 3 | 0.0 % | 0.0 % | -1.5 | 35.8 % | 4.2 % | 2.7 (7) | |
| BKSY Blacksky Technology Inc | 08/06 | +25 % | ⚠ Wildest 10% 105 % | Stage 1 | C 46 | 2 of 9 | 0.9 $ | Specialty Business Services | Sells AI | — | — | Industrials | 22.80 $ | +43.5 % | +33.6 % | +18.8 % | −54.0 % | +68.5 % | 76 | 42 | 9.1 % | 10.7 % | 2.61 | — | 0.0 | 7.9 | — | — | — | 6.6 | — | 69.9 % | -61.2 % | -102.7 % | -7.5 % | — | — | +4.4 % | 5 | 0.0 % | 0.0 % | -2.1 | 68.4 % | 17.4 % | 5.0 (6) |
| CABA Cabaletta Bio Inc | 08/06 | -25 % | ⚠ Wildest 10% 95 % | Stage 2 | D 37 | 2 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | +37.9 % | +42.0 % | +34.4 % | −31.0 % | +409.6 % | 73 | 42 | 7.4 % | 7.4 % | 3.26 | — | 0.0 | — | — | — | — | -3.4 | — | — | 0.0 % | -156.0 % | -48.2 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -10.9 | 63.6 % | 26.9 % | 4.5 (12) |
| TEAD Teads B.V. | 08/06 | -26 % | ⚠ Wildest 10% 124 % | Stage 3 | D 35 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 0.5473 $ | +65.5 % | -10.0 % | -67.6 % | −65.2 % | +89.9 % | 72 | 30 | 13.2 % | 12.5 % | 1.63 | — | 0.0 | 0.0 | 1.1 | — | — | 98.7 | — | 33.2 % | -43.3 % | -190.9 % | -1.7 % | 13.00 | — | +46.1 % | 3 | 0.0 % | 0.0 % | -0.7 | 30.0 % | 7.6 % | 3.4 (5) |
| SCLX Scilex Holding Company | 08/12 | -32 % | ⚠ Wildest 10% 106 % | Stage 3 | D 38 | 4 of 9 | 0.0 $ | Drug Manufacturers - General | Neutral | — | — | Healthcare | 5.40 $ | -9.4 % | -9.4 % | -65.5 % | −79.3 % | +9,323.1 % | 72 | 42 | 13.4 % | 12.2 % | 1.72 | — | 5.6 | 1.3 | — | — | — | -2.6 | — | 55.5 % | 0.0 % | 0.0 % | -105.8 % | — | — | -46.5 % | 3 | 0.0 % | 0.0 % | -26.0 | 13.1 % | 2.9 % | 4.0 (2) |
| PRKS United Parks & Resorts Inc | 08/06 | -6 % | 52 % | Stage 3 | D 36 | 4 of 9 | 1.7 $ | Leisure | – | — | — | Consumer Cyclical | 35.70 $ | +27.5 % | +31.1 % | -29.4 % | −18.5 % | +32.5 % | 67 | 16 | 3.7 % | 4.7 % | 1.14 | 13.8 | 10.7 | 1.0 | 141.7 | 6.3 | — | 8.2 | -2.8 % | 46.0 % | 8.1 % | 0.0 % | 7.8 % | -4.29 | -21.4 % | -3.6 % | 3 | 0.0 % | 0.0 % | 4.4 | 141.1 % | 34.7 % | 3.7 (12) |
| BALY Bally's Corp | 08/10 | +0 % | 78 % | Stage 3 | C 46 | 4 of 9 | 0.5 $ | Resorts & Casinos | – | — | — | Consumer Cyclical | 10.40 $ | -12.2 % | -22.6 % | -1.1 % | −30.3 % | -3.8 % | 65 | 99 | 8.2 % | 7.2 % | 2.05 | — | 45.9 | 0.2 | — | — | — | 71.9 | — | 57.7 % | -25.8 % | -54.6 % | -0.1 % | — | — | +8.4 % | 2 | 0.0 % | 0.0 % | 3.1 | 77.5 % | 10.7 % | 3.0 (5) |
| ZBIO Zenas BioPharma, Inc. | 08/11 | — | ⚠ Wildest 10% 116 % | Stage 4 | D 35 | 2 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 32.00 $ | -44.4 % | -40.8 % | +67.7 % | −44.7 % | +46.9 % | 57 | 42 | 8.2 % | 7.6 % | -1.02 | — | 0.0 | 2,083.0 | — | — | — | 0.0 | — | -21,247.3 % | 0.0 % | -137.1 % | -34.4 % | — | — | +100.0 % | 5 | 0.0 % | 0.0 % | 2.6 | 90.5 % | 26.4 % | 4.7 (7) |
| BIRD Allbirds Inc | 08/06 | -32 % | ⚠ Wildest 10% 219 % | Stage 3 | D 28 | 3 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 2.40 $ | +24.9 % | -84.6 % | -54.2 % | −82.4 % | +483.3 % | 57 | 42 | 23.0 % | 13.8 % | 2.62 | — | 0.0 | 0.3 | 1.3 | — | — | -0.6 | — | 40.3 % | -49.6 % | -153.7 % | -54.3 % | 2.04 | — | -19.7 % | 1 | 12.6 % | 0.0 % | -23.1 | 35.4 % | 15.2 % | 3.2 (5) |
| KULR KULR Technology Group Inc | 08/13 | -9 % | ⚠ Wildest 10% 99 % | Stage 2 | D 40 | 4 of 9 | 0.1 $ | Electronic Components | – | — | — | Technology | 2.40 $ | +30.4 % | +11.8 % | -46.9 % | −52.9 % | +204.3 % | 56 | 42 | 9.7 % | 11.7 % | 2.31 | — | 128.2 | 6.6 | — | — | — | -6.4 | — | -14.9 % | 0.0 % | -77.3 % | -22.8 % | — | — | +50.6 % | 5 | 0.0 % | 0.0 % | 2.9 | 22.6 % | 15.2 % | 5.0 (2) |
| NEXT Nextdecade Corp | 07/30 | -1 % | 61 % | Stage 2 | D 29 | 1 of 9 | 1.7 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 7.00 $ | +27.7 % | +28.2 % | +7.2 % | −40.8 % | +24.3 % | 54 | 50 | 7.0 % | 5.7 % | 1.57 | — | 0.0 | — | 22.6 | — | — | 18.9 | 0.0 % | — | 0.0 % | -18.6 % | -1.2 % | 89.31 | 0.8 % | — | — | 0.0 % | 0.0 % | -0.1 | 45.0 % | 14.6 % | 3.5 (2) | |
| AURA Aura Biosciences Inc | 08/12 | -15 % | 56 % | Stage 2 | D 29 | 1 of 9 | 0.7 $ | Biotechnology | Neutral | — | Healthcare | 6.60 $ | +28.8 % | +17.0 % | +8.0 % | −28.1 % | +151.5 % | 54 | 42 | 6.5 % | 5.5 % | 0.40 | — | 0.0 | — | 6.5 | — | — | -5.7 | — | — | 0.0 % | -95.6 % | -31.2 % | 0.16 | — | — | 2 | 0.0 % | 0.0 % | -5.9 | 51.0 % | 6.0 % | 4.6 (7) | |
| PDSB PDS Biotechnology Corp | 08/12 | -28 % | ⚠ Wildest 10% 164 % | Stage 2 | D 39 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.8422 $ | +18.5 % | +0.6 % | -26.8 % | −44.8 % | +379.5 % | 53 | 42 | 9.6 % | 11.2 % | 1.45 | — | 0.0 | — | 12.2 | — | — | -2.6 | — | — | 0.0 % | -254.1 % | -70.6 % | 4.08 | — | — | 2 | 0.0 % | 0.0 % | -28.7 | 9.2 % | 4.4 % | 4.7 (3) |
| SRI Stoneridge Inc | 08/05 | -20 % | 61 % | Stage 2 | D 32 | 3 of 9 | 0.2 $ | Auto Parts | – | — | — | Consumer Cyclical | 7.20 $ | +18.7 % | +33.7 % | -12.3 % | −27.3 % | +104.2 % | 49 | 90 | 5.2 % | 5.5 % | 1.89 | — | 20.3 | 0.3 | 1.3 | — | 0.26 | 15.4 | — | 19.3 % | -13.3 % | -53.6 % | -1.7 % | 1.04 | — | -5.2 % | 3 | 0.0 % | 0.0 % | 5.7 | 84.3 % | 4.1 % | 4.5 (2) |
| RGNX Regenxbio Inc | 08/06 | -16 % | ⚠ Wildest 10% 99 % | Stage 4 | D 38 | 1 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 8.20 $ | -30.9 % | -18.2 % | -9.0 % | −36.8 % | +200.3 % | 46 | 42 | 13.1 % | 9.4 % | 0.93 | — | 0.0 | 2.4 | — | — | 0.26 | -3.4 | — | -45.0 % | -112.6 % | -196.4 % | -21.2 % | — | — | +104.5 % | 4 | 0.0 % | 0.0 % | -10.9 | 84.7 % | 12.0 % | 4.4 (12) |
| OSTX OS Therapies Incorporated | 08/17 | — | 73 % | Stage 3 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.80 $ | +30.0 % | +47.4 % | -16.8 % | −30.0 % | +372.2 % | 45 | 42 | 8.5 % | 8.3 % | -0.68 | — | 1.7 | — | 13.6 | — | — | 0.0 | — | — | 0.0 % | -914.0 % | -232.6 % | -0.12 | — | — | — | 0.0 % | 0.0 % | -78.9 | 6.5 % | 6.4 % | 4.8 (4) |
| FSI Flexible Solutions International Inc | 08/13 | +50 % | 47 % | Stage 3 | C 45 | 3 of 9 | 0.1 $ | Specialty Chemicals | – | — | — | Basic Materials | 5.90 $ | -4.2 % | -4.2 % | -42.3 % | −44.4 % | +46.6 % | 44 | 77 | 3.8 % | 3.4 % | 1.72 | 101.5 | 8.8 | 2.1 | 2.0 | — | 7.67 | 296.9 | — | 19.1 % | -8.8 % | 5.6 % | -2.1 % | 0.34 | — | +0.7 % | 6 | 0.0 % | 0.0 % | 8.7 | 10.4 % | 1.0 % | 5.0 (1) |
| SPCE Virgin Galactic Holdings Inc | 08/05 | -32 % | ⚠ Wildest 10% 113 % | Stage 1 | C 45 | 3 of 9 | 0.3 $ | Aerospace & Defense | Neutral | — | Industrials | 3.10 $ | -6.5 % | -12.0 % | -4.3 % | −71.9 % | +18.7 % | 43 | 42 | 11.4 % | 18.9 % | 2.81 | — | 0.0 | 341.0 | — | — | — | -0.1 | — | -9,106.1 % | 0.0 % | -104.5 % | -19.0 % | — | — | -78.1 % | 2 | 0.0 % | 0.0 % | -10.8 | 15.8 % | 23.8 % | 2.9 (9) | |
| SANA Sana Biotechnology Inc | 08/10 | -26 % | 82 % | Stage 4 | D 38 | 2 of 9 | 0.9 $ | Biotechnology | – | — | — | Healthcare | 3.10 $ | -17.7 % | -23.8 % | +2.0 % | −50.2 % | +163.4 % | 41 | 50 | 7.7 % | 7.0 % | 2.13 | — | 0.0 | — | 7.4 | — | — | -1.1 | — | — | 0.0 % | -147.4 % | -29.2 % | 0.63 | — | — | — | 0.0 % | 0.0 % | -15.9 | 82.8 % | 23.4 % | 4.4 (8) |
| FRPH Frp Holdings Ord | 08/05 | -4 % | 26 % | Stage 3 | D 33 | 3 of 9 | 0.4 $ | Real Estate Services | – | — | — | Real Estate | 21.30 $ | +7.7 % | +12.4 % | -14.5 % | −11.7 % | +107.4 % | 41 | 7 | 3.0 % | 2.6 % | 0.52 | 422.2 | 17.4 | 9.2 | 0.9 | 28.1 | 1.12 | 39.3 | — | 63.4 % | 0.3 % | 0.1 % | -0.3 % | 0.48 | — | +2.6 % | 5 | 0.0 % | 0.0 % | 7.1 | 47.4 % | 3.6 % | — |
| ELUT Elutia Inc. | 08/13 | -20 % | 73 % | Stage 2 | D 39 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.85 $ | +48.7 % | +71.0 % | -24.8 % | −64.1 % | +517.3 % | 41 | 42 | 7.1 % | 8.1 % | 0.88 | — | 0.0 | 3.9 | 1.8 | — | — | -3.3 | — | 57.8 % | 426.9 % | 0.0 % | -34.7 % | 0.52 | — | -49.6 % | 3 | 0.0 % | 0.0 % | -7.2 | 45.7 % | 0.0 % | 5.0 (2) |
| NG NovaGold Resources Inc | — | +19 % | 80 % | Stage 4 | D 33 | 4 of 9 | 3.2 $ | Gold | – | — | — | Basic Materials | 7.40 $ | -22.5 % | -39.5 % | +5.5 % | −57.3 % | +79.0 % | 40 | 42 | 8.2 % | 6.7 % | 2.26 | — | 4.9 | — | — | — | 1.34 | -40.4 | 0.0 % | — | 0.0 % | -52.0 % | -4.4 % | — | 70.3 % | -100.0 % | 1 | 0.0 % | 0.0 % | -2.2 | 79.3 % | 9.0 % | 4.4 (8) |
| MXCT MaxCyte Inc | 08/05 | -25 % | 68 % | Stage 3 | C 47 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 1.20 $ | -24.2 % | -22.5 % | -20.3 % | −46.4 % | +242.3 % | 40 | 42 | 6.6 % | 7.0 % | 1.53 | — | 0.0 | 4.2 | — | — | — | -11.1 | — | 79.2 % | -114.8 % | -21.3 % | -10.6 % | — | — | -14.5 % | 4 | 0.0 % | 0.0 % | 7.9 | 68.0 % | 1.3 % | 5.0 (6) |
| RICK RCI Hospitality Holdings Inc | 08/10 | -21 % | 45 % | Stage 3 | D 39 | 4 of 9 | 0.2 $ | Restaurants | – | — | — | Consumer Cyclical | 28.50 $ | +13.6 % | +18.5 % | +11.7 % | −34.6 % | +250.0 % | 38 | 93 | 4.0 % | 4.1 % | 0.79 | — | 6.8 | 0.8 | 1.0 | 5.3 | 0.79 | 13.8 | — | 85.0 % | -1.5 % | -2.5 % | 4.2 % | 1.21 | — | -5.5 % | 4 | 1.1 % | 39.2 % | 4.9 | 48.4 % | 9.9 % | — |
| GENC Gencor Industries Inc | 08/14 | +1 % | 39 % | Stage 2 | C 53 | 4 of 9 | 0.3 $ | Farm & Heavy Construction Machinery | Neutral | — | — | Industrials | 17.00 $ | +23.5 % | +5.3 % | +15.6 % | −2.8 % | +11.1 % | 38 | 18 | 2.6 % | 3.0 % | 0.53 | 17.3 | 28.5 | 2.3 | 1.0 | — | — | 6.0 | 12.5 % | 28.6 % | 13.5 % | 6.1 % | 3.5 % | 0.00 | 95.2 % | +2.0 % | 4 | 0.0 % | 0.0 % | 16.1 | 61.2 % | 0.9 % | — |
| QS QuantumScape Corporation | 07/22 | +3 % | 79 % | Stage 4 | D 37 | 4 of 9 | 3.3 $ | Auto Parts | Uses AI | — | — | Consumer Cyclical | 5.20 $ | -28.8 % | -32.1 % | -49.6 % | −62.6 % | +28.1 % | 36 | 42 | 7.6 % | 7.9 % | 2.69 | — | 0.0 | — | 2.8 | — | — | -7.2 | 0.0 % | — | 0.0 % | -38.0 % | -24.3 % | 0.06 | 90.3 % | — | 3 | 0.0 % | 0.0 % | 5.0 | 41.9 % | 19.5 % | 2.7 (9) |
| IMMR Immersion Corporation | 08/07 | +3 % | 43 % | Stage 3 | D 36 | 1 of 9 | 0.3 $ | Software - Application | – | — | — | Technology | 7.50 $ | -1.0 % | +1.6 % | +10.4 % | −18.0 % | +90.1 % | 35 | 11 | 4.7 % | 4.3 % | 1.00 | — | 28.2 | 0.2 | — | — | 2.21 | 3.2 | — | 21.5 % | 0.6 % | 19.6 % | 1.1 % | — | — | +12.0 % | 5 | 4.2 % | 57.2 % | 5.8 | 52.0 % | 7.8 % | 4.5 (2) |
| SACH Sachem Capital Corp | 08/04 | -19 % | 55 % | Stage 1 | E 18 | 4 of 9 | 0.0 $ | REIT - Mortgage | – | — | — | Real Estate | 0.9599 $ | -4.2 % | +0.6 % | -8.3 % | −35.5 % | +26.5 % | 33 | 23 | 3.9 % | 6.9 % | 1.21 | — | 18.0 | — | — | — | 0.15 | 10.7 | — | 100.0 % | -82.7 % | -0.4 % | -1.6 % | — | — | -18.2 % | 2 | 4.2 % | 500.0 % | 4.1 | 19.6 % | 0.5 % | 3.4 (5) |
| PRME Prime Medicine, Inc. | 08/06 | -26 % | ⚠ Wildest 10% 86 % | Stage 4 | D 43 | 1 of 9 | 0.6 $ | Biotechnology | – | — | — | Healthcare | 3.10 $ | -6.6 % | +4.2 % | -32.5 % | −54.2 % | +122.3 % | 32 | 42 | 10.1 % | 9.0 % | 2.35 | — | 0.0 | — | 7.9 | — | — | -3.1 | — | -3,489.5 % | 0.0 % | -216.1 % | -46.5 % | 1.49 | — | +55.3 % | 4 | 0.0 % | 0.0 % | -9.0 | 66.6 % | 25.9 % | 4.2 (12) |
| ELWT Elauwit Connection, Inc. | 08/13 | — | – | Stage 1 | D 29 | 3 of 9 | 0.0 $ | Telecom Services | – | — | — | Communication Services | 7.20 $ | +18.9 % | +30.7 % | — | −36.8 % | +42.9 % | 31 | 42 | 10.5 % | 10.2 % | — | — | 0.0 | 2.7 | 20.7 | — | — | 0.0 | — | 17.7 % | -45.3 % | 0.0 % | -47.8 % | 0.82 | — | +154.5 % | 5 | 0.0 % | 0.0 % | -4.6 | 8.6 % | 0.8 % | — |
| GNLX Genelux Corporation | 08/06 | -31 % | 84 % | Stage 4 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 2.50 $ | -33.0 % | -34.1 % | -35.3 % | −66.0 % | +726.1 % | 28 | 42 | 6.2 % | 5.6 % | 0.56 | — | 0.0 | — | 4.5 | — | — | -327.2 | — | 100.0 % | 0.0 % | -127.3 % | -77.9 % | 0.11 | — | +0.0 % | 3 | 0.0 % | 0.0 % | -26.5 | 30.7 % | 8.6 % | 4.6 (5) |
| GROV Grove Collaborative Holdings, Inc. | 08/06 | -9 % | 52 % | Stage 4 | C 53 | 4 of 9 | 0.0 $ | Household & Personal Products | – | — | — | Consumer Defensive | 1.10 $ | +10.9 % | +9.4 % | -30.5 % | −32.1 % | +100.0 % | 28 | 42 | 5.6 % | 6.3 % | 1.03 | — | 0.1 | 0.3 | — | — | — | -3.4 | — | 53.6 % | -4.1 % | -89.6 % | -6.9 % | — | — | -14.6 % | 3 | 0.0 % | 0.0 % | -38.9 | 30.4 % | 9.0 % | 4.0 (2) |
| SPRU Spruce Power Holding Corp | 08/10 | -20 % | ⚠ Wildest 10% 95 % | Stage 4 | C 45 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 1.60 $ | -46.6 % | -49.9 % | -7.4 % | −61.9 % | +275.0 % | 27 | 42 | 4.6 % | 6.3 % | 1.19 | — | 45.2 | 0.3 | 0.3 | 280.0 | — | 8.8 | — | 66.4 % | -6.8 % | -10.5 % | 1.8 % | 5.76 | — | +36.2 % | 6 | 0.0 % | 0.0 % | 1.4 | 35.7 % | 5.8 % | — |
| FBRX Forte Biosciences Inc | 08/13 | -23 % | ⚠ Wildest 10% 118 % | Stage 1 | D 25 | 3 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 77.00 $ | -33.4 % | -22.3 % | +585.6 % | −47.7 % | -5.2 % | 26 | 42 | 7.7 % | 8.6 % | 2.65 | — | 0.0 | — | 10.3 | — | — | 1.9 | — | — | 0.0 % | -188.4 % | -37.8 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -10.3 | 74.8 % | 7.7 % | 5.0 (4) |
| FIP FTAI Infrastructure Inc. | 08/06 | +16 % | 69 % | Stage 4 | D 38 | 4 of 9 | 0.3 $ | Conglomerates | Neutral | — | — | Industrials | 2.80 $ | +1.7 % | -8.6 % | -40.0 % | −38.1 % | +242.7 % | 25 | 42 | 6.2 % | 6.5 % | 1.89 | — | 83.3 | 0.5 | 16.2 | — | — | 57.5 | — | 40.0 % | -83.4 % | -61.1 % | 0.8 % | 3.91 | — | +51.6 % | 4 | 4.0 % | 0.0 % | 3.1 | 86.4 % | 26.8 % | 4.7 (3) |
| DXLG Destination XL Group Inc | — | -29 % | ⚠ Wildest 10% 86 % | Stage 4 | D 29 | 2 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 0.647 $ | -24.8 % | -29.1 % | -54.1 % | −61.5 % | +98.5 % | 24 | 7 | 8.2 % | 8.1 % | 1.28 | — | 149.3 | 0.1 | 0.4 | — | 1.60 | 60.5 | — | 43.9 % | -8.8 % | -32.8 % | -2.0 % | 2.08 | — | -6.9 % | 3 | 0.0 % | 0.0 % | 2.9 | 67.3 % | 2.0 % | 4.0 (2) |
| ULBI Ultralife Corporation | 08/06 | +10 % | 56 % | Stage 1 | C 49 | 4 of 9 | 0.1 $ | Electrical Equipment & Parts | – | — | — | Industrials | 5.60 $ | +7.7 % | +2.0 % | -18.4 % | −34.6 % | +154.5 % | 24 | 8 | 4.0 % | 6.0 % | 0.83 | — | 15.3 | 0.5 | 0.7 | 46.0 | 3.81 | 149.7 | — | 24.4 % | -3.5 % | -6.2 % | 2.1 % | 0.37 | — | +16.2 % | 3 | 0.0 % | 0.0 % | 5.9 | 73.8 % | 1.1 % | 5.0 (1) |
| ESLA Estrella Immunopharma Inc. | — | -32 % | ⚠ Wildest 10% 112 % | Stage 4 | D 43 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.526 $ | -35.9 % | -35.2 % | -55.0 % | −69.8 % | +1,775.3 % | 23 | 42 | 8.2 % | 8.7 % | 0.89 | — | 0.0 | — | 2.3 | — | — | -3.1 | — | — | 0.0 % | -268.5 % | -251.9 % | — | — | — | — | 0.0 % | 0.0 % | -54.7 | 12.2 % | 0.7 % | 5.0 (1) |
| FTCI FTC Solar Inc | 08/04 | -30 % | ⚠ Wildest 10% 111 % | Stage 4 | D 40 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 2.10 $ | -52.2 % | -58.7 % | -69.5 % | −64.2 % | +322.6 % | 22 | 42 | 9.6 % | 9.9 % | 1.84 | — | 18.8 | 0.3 | 5.4 | — | — | -0.7 | — | 3.0 % | -53.6 % | -955.8 % | -26.2 % | -3.81 | — | +110.5 % | 3 | 0.0 % | 0.0 % | -10.6 | 10.1 % | 13.7 % | 3.8 (4) |
| TELO Telomir Pharmaceuticals, Inc. | 08/13 | — | 73 % | Stage 4 | D 30 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -6.0 % | -12.0 % | -15.8 % | −60.3 % | +1,309.1 % | 21 | 42 | 6.0 % | 5.5 % | -0.25 | — | 0.0 | — | 15.6 | — | — | 0.0 | — | — | 0.0 % | -384.3 % | -122.8 % | 0.04 | — | — | 4 | 0.0 % | 0.0 % | -14.4 | 3.3 % | 1.5 % | — |
| BKKT Bakkt Holdings Inc | 08/10 | -30 % | ⚠ Wildest 10% 129 % | Stage 4 | E 23 | 3 of 9 | 0.3 $ | Software - Infrastructure | – | — | — | Technology | 7.50 $ | -11.7 % | -23.3 % | -22.9 % | −84.3 % | +55.8 % | 20 | 42 | 9.7 % | 10.7 % | 5.93 | — | 0.0 | — | 2.0 | — | — | 0.8 | — | -9.9 % | -2.8 % | -102.0 % | -25.0 % | 0.00 | — | -33.1 % | 4 | 0.0 % | 0.0 % | -7.7 | 21.4 % | 25.5 % | — |
| TVGN Tevogen Bio Holdings Inc. | 08/18 | -33 % | ⚠ Wildest 10% 115 % | Stage 4 | D 25 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 7.70 $ | -42.5 % | -68.2 % | -81.6 % | −20.7 % | -74.4 % | 20 | 42 | 12.9 % | 16.1 % | 0.19 | — | 0.0 | — | 0.0 | — | — | 18.3 | — | — | 0.0 % | 0.0 % | -297.4 % | -0.31 | — | — | — | 0.0 % | 0.0 % | -129.5 | 3.6 % | 1.6 % | 5.0 (1) |
| AZTA Azenta Inc | 08/04 | -16 % | 64 % | Stage 4 | C 51 | 3 of 9 | 1.5 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 33.60 $ | -33.3 % | -26.1 % | +10.4 % | −41.0 % | +4.9 % | 19 | 99 | 4.7 % | 5.0 % | 1.39 | — | 29.1 | 2.5 | 1.0 | 179.5 | 0.53 | 35.7 | — | 44.1 % | -20.0 % | -6.8 % | -0.7 % | 0.04 | — | +3.6 % | 5 | 0.0 % | 0.0 % | 11.1 | 120.4 % | 19.9 % | 3.4 (7) |
| CMTL Comtech Telecommunications Corp | — | -29 % | ⚠ Wildest 10% 99 % | Stage 1 | C 46 | 4 of 9 | 0.0 $ | Communication Equipment | – | — | — | Technology | 1.50 $ | -54.8 % | -54.1 % | -37.5 % | −67.0 % | +183.3 % | 18 | 95 | 14.2 % | 10.9 % | 1.51 | — | 5.3 | 0.1 | 0.9 | 2.9 | 0.66 | 8.5 | — | 33.0 % | -5.5 % | -9.1 % | 0.4 % | 0.96 | — | -7.6 % | 1 | 0.0 % | 0.0 % | 4.5 | 54.4 % | 1.4 % | 4.0 (2) |
| ARCT Arcturus Therapeutics Holdings Inc | 08/10 | -24 % | ⚠ Wildest 10% 103 % | Stage 4 | D 27 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 16.90 $ | +15.5 % | +4.9 % | -6.2 % | −71.8 % | +41.1 % | 16 | 42 | 5.9 % | 5.8 % | 2.48 | — | 2.5 | 17.2 | 2.4 | — | — | -25.7 | — | -195.5 % | 0.0 % | -37.0 % | -24.0 % | 0.13 | — | -51.4 % | 4 | 0.0 % | 0.0 % | 2.7 | 80.3 % | 26.7 % | 4.7 (11) |
| EXOZ eXoZymes, Inc. | 08/11 | — | 76 % | Stage 4 | E 20 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 6.20 $ | -29.4 % | -32.5 % | -54.6 % | −59.8 % | — | 16 | 42 | 12.9 % | 9.0 % | — | — | 0.0 | — | 38.5 | — | — | 0.0 | — | — | 0.0 % | -185.8 % | -74.7 % | 0.76 | — | — | — | 0.0 % | 0.0 % | -31.3 | 0.7 % | 0.4 % | — |
| USGO U.S. GoldMining Inc. | 08/13 | -12 % | 69 % | Stage 4 | E 24 | 4 of 9 | 0.1 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 7.70 $ | -6.1 % | -12.3 % | -18.0 % | −55.8 % | +382.7 % | 16 | 42 | 6.0 % | 6.8 % | 1.88 | — | 0.0 | — | 16.8 | — | — | -7.1 | — | — | 0.0 % | -159.5 % | -101.0 % | 0.01 | — | — | 3 | 0.0 % | 0.0 % | -2.6 | 9.0 % | 7.8 % | 4.0 (1) |
| OPTU Optimum Communications, Inc. | 08/06 | -12 % | ⚠ Wildest 10% 101 % | Stage 4 | D 29 | 4 of 9 | 0.4 $ | Telecom Services | – | — | — | Communication Services | 1.00 $ | -18.2 % | -10.6 % | -58.7 % | −46.3 % | +6.7 % | 15 | 50 | 13.6 % | 16.5 % | 1.25 | — | 2.0 | 0.0 | 41.6 | — | 1.34 | 16.7 | — | 69.9 % | -58.2 % | 0.0 % | 2.8 % | -5.13 | — | -4.1 % | 4 | 0.0 % | 0.0 % | 2.1 | 102.3 % | 38.0 % | — |
| INMB INmune Bio Inc | 08/06 | -28 % | 72 % | Stage 4 | C 52 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 2.20 $ | -9.0 % | -8.5 % | +14.1 % | −87.2 % | +233.3 % | 15 | 42 | 11.0 % | 7.8 % | 0.94 | — | 0.0 | — | — | — | — | -5.3 | — | — | 0.0 % | -168.8 % | -39.1 % | — | — | +257.1 % | 4 | 0.0 % | 0.0 % | -20.5 | 19.7 % | 8.8 % | 4.4 (5) |
| RR Richtech Robotics Inc. | 07/01 | — | ⚠ Wildest 10% 108 % | Stage 4 | C 46 | 4 of 9 | 0.4 $ | Specialty Industrial Machinery | – | — | — | Industrials | 1.70 $ | -37.5 % | -45.8 % | -57.0 % | −74.6 % | +25.0 % | 15 | 42 | 7.4 % | 9.5 % | -0.59 | — | 0.0 | 70.2 | 1.1 | — | — | 3.7 | — | 58.9 % | -81.8 % | -10.6 % | -7.4 % | 0.00 | — | +19.0 % | 3 | 0.0 % | 0.0 % | 45.2 | 40.4 % | 25.3 % | 4.7 (3) |
| TCRX Tscan Therapeutics Inc | 08/11 | -22 % | ⚠ Wildest 10% 107 % | Stage 4 | D 34 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.3335 $ | -7.9 % | -6.0 % | -79.2 % | −67.3 % | +705.6 % | 13 | 42 | 10.4 % | 7.8 % | 1.07 | — | 0.0 | 3.1 | 0.2 | — | — | 0.4 | — | -1,242.1 % | 0.0 % | -81.0 % | -31.5 % | 0.96 | — | +266.7 % | 2 | 0.0 % | 0.0 % | -4.8 | 59.5 % | 3.7 % | 4.5 (8) |
| QSI QuantumSi Inc | 08/04 | -25 % | ⚠ Wildest 10% 87 % | Stage 4 | D 41 | 1 of 9 | 0.2 $ | Medical Devices | – | — | — | Healthcare | 0.7745 $ | -20.0 % | -32.1 % | -38.9 % | −72.4 % | +215.0 % | 12 | 42 | 9.5 % | 9.4 % | 3.25 | — | 0.0 | 101.2 | 0.8 | — | — | 0.6 | — | 35.0 % | 0.0 % | -46.4 % | -25.7 % | 0.02 | — | -20.3 % | 6 | 0.0 % | 0.0 % | 9.5 | 29.9 % | 8.1 % | 4.0 (3) |
| MYPS Playstudios Inc | 08/03 | -30 % | 76 % | Stage 4 | D 35 | 4 of 9 | 0.1 $ | Electronic Gaming & Multimedia | Neutral | — | Communication Services | 0.4848 $ | -21.0 % | -27.7 % | -49.1 % | −68.6 % | +0.0 % | 12 | 53 | 13.3 % | 13.0 % | 0.97 | — | 208.3 | 0.3 | 0.3 | 2.7 | 7.00 | 0.2 | — | 77.9 % | -20.7 % | -15.7 % | -6.2 % | 0.03 | — | -18.8 % | 4 | 0.0 % | 0.0 % | 7.3 | 37.9 % | 0.4 % | 3.8 (5) | |
| RNTX Rein Therapeutics Inc | 08/13 | -25 % | ⚠ Wildest 10% 87 % | Stage 4 | D 31 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.7892 $ | -16.5 % | -21.2 % | -31.4 % | −57.1 % | +754.6 % | 12 | 42 | 8.9 % | 8.4 % | 1.37 | — | 0.0 | — | — | — | — | -0.6 | — | — | 0.0 % | -163.4 % | -21.0 % | — | — | — | 1 | 0.0 % | 0.0 % | -60.0 | 24.6 % | 0.8 % | 5.0 (1) |
| TCX Tucows Inc. | 08/06 | -17 % | 74 % | Stage 4 | D 31 | 3 of 9 | 0.1 $ | Software - Infrastructure | – | — | — | Technology | 10.20 $ | -39.0 % | -38.1 % | -44.7 % | −47.0 % | +1,370.7 % | 11 | 84 | 4.6 % | 4.4 % | 0.85 | — | 30.5 | 0.3 | — | — | 1.89 | 22.2 | — | 35.5 % | -21.2 % | -1,011.6 % | -1.7 % | — | — | +7.7 % | 3 | 0.0 % | 0.0 % | 0.3 | 68.6 % | 14.6 % | — |
| COCH Envoy Medical Inc. | 07/30 | -33 % | ⚠ Wildest 10% 132 % | Stage 4 | D 35 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 0.6802 $ | -1.7 % | -8.8 % | -48.5 % | −64.4 % | +181.7 % | 11 | 42 | 10.6 % | 7.5 % | 1.90 | — | 0.0 | 265.0 | — | — | — | -1.4 | — | -293.7 % | 0.0 % | 0.0 % | -86.5 % | — | — | +7.1 % | 3 | 0.0 % | 0.0 % | -32.6 | 22.9 % | 1.3 % | 5.0 (4) |
| ULH Universal Logistics Holdings Inc | 07/23 | -15 % | ⚠ Wildest 10% 88 % | Stage 4 | D 41 | 3 of 9 | 0.5 $ | Trucking | – | — | — | Industrials | 18.00 $ | -2.4 % | -2.8 % | -22.3 % | −50.5 % | -15.3 % | 10 | 6 | 6.3 % | 6.6 % | 0.76 | — | 11.2 | 0.3 | 0.9 | 13.1 | 3.73 | 5.5 | — | 19.1 % | -6.0 % | -18.5 % | 1.2 % | 1.73 | — | -15.6 % | 4 | 2.2 % | 4.2 % | 4.6 | 28.6 % | 13.3 % | 3.0 (1) |
| TELA Tela Bio Inc | 08/10 | -31 % | ⚠ Wildest 10% 90 % | Stage 4 | D 42 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 1.30 $ | -33.4 % | -35.9 % | -14.6 % | −66.4 % | +75.0 % | 10 | 42 | 12.2 % | 11.7 % | 1.36 | — | 0.0 | 1.0 | 13.6 | — | — | -5.0 | — | 68.3 % | -51.5 % | -616.6 % | -33.4 % | -10.84 | — | +15.8 % | 5 | 0.0 % | 0.0 % | -14.8 | 69.0 % | 1.2 % | 4.4 (5) |
| LAB Standard Biotools Inc | 08/10 | -20 % | 72 % | Stage 4 | D 39 | 3 of 9 | 0.3 $ | Medical Devices | – | — | — | Healthcare | 0.73 $ | -38.1 % | -49.2 % | -45.9 % | −57.0 % | +90.4 % | 9 | 50 | 8.1 % | 8.3 % | 1.37 | — | 0.0 | 3.4 | 0.5 | — | — | -19.2 | — | 50.5 % | 100.4 % | -9.9 % | -6.6 % | 0.05 | — | -51.1 % | 3 | 0.0 % | 0.0 % | 9.0 | 76.7 % | 1.3 % | 4.3 (3) |
| MCRB Seres Therapeutics Inc | 08/05 | -31 % | ⚠ Wildest 10% 96 % | Stage 4 | D 31 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.10 $ | -52.6 % | -49.1 % | -76.7 % | −77.2 % | +304.8 % | 9 | 3 | 11.2 % | 9.5 % | 0.22 | — | 10.8 | 21.6 | — | — | — | 3.5 | — | -2,447.2 % | 0.0 % | -121.9 % | -39.9 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -25.9 | 24.4 % | 4.6 % | 3.6 (5) |
| NTHI NeOnc Technologies Holdings, Inc. | 08/17 | — | ⚠ Wildest 10% 112 % | Stage 4 | D 25 | 3 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 3.40 $ | -41.0 % | -46.9 % | -67.9 % | −65.3 % | +433.3 % | 9 | 42 | 10.7 % | 9.8 % | — | — | 0.0 | — | 0.0 | — | — | 0.0 | — | 100.0 % | 0.0 % | 0.0 % | -635.0 % | -0.03 | — | -51.8 % | 5 | 0.0 % | 0.0 % | -188.6 | 11.1 % | 4.4 % | — | |
| CRVO CervoMed Inc. | 08/14 | -28 % | ⚠ Wildest 10% 99 % | Stage 4 | D 34 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | -52.9 % | -79.6 % | -67.3 % | −74.5 % | +541.7 % | 8 | 42 | 21.8 % | 12.8 % | -4.31 | — | 0.0 | 70.0 | 2.5 | — | — | 1.6 | — | -6,337.7 % | 0.0 % | -132.8 % | -60.8 % | — | — | -58.9 % | 4 | 0.0 % | 0.0 % | -18.8 | 13.3 % | 10.9 % | 4.6 (7) |
| PETS PetMed Express Inc | — | -29 % | ⚠ Wildest 10% 88 % | Stage 4 | D 28 | 3 of 9 | 0.0 $ | Pharmaceutical Retailers | – | — | — | Healthcare | 1.60 $ | -42.8 % | -48.7 % | -41.7 % | −56.8 % | +34.4 % | 8 | 92 | 6.3 % | 5.9 % | 0.79 | — | 16.7 | 0.2 | — | — | 2.32 | 0.6 | — | 27.9 % | -17.3 % | -100.4 % | -20.1 % | — | — | -34.7 % | 3 | 0.0 % | 0.0 % | 1.5 | 44.8 % | 4.0 % | 2.0 (2) |
| RMTI Rockwell Medical Inc | 08/13 | -28 % | 65 % | Stage 4 | D 31 | 4 of 9 | 0.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 7.90 $ | -19.9 % | -27.4 % | -50.9 % | −69.0 % | +156.4 % | 8 | 42 | 6.4 % | 5.9 % | 1.64 | — | 21.6 | 0.6 | 0.9 | 19.1 | 4.43 | 30.2 | — | 17.7 % | -7.3 % | -16.0 % | -5.2 % | 0.40 | — | -31.8 % | 2 | 0.0 % | 0.0 % | -15.4 | 10.1 % | 2.4 % | 4.0 (2) |
| SKYE Skye Bioscience, Inc. | 08/06 | -29 % | ⚠ Wildest 10% 238 % | Stage 4 | D 36 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.60 $ | -6.7 % | -19.6 % | -59.9 % | −87.7 % | +3,900.0 % | 8 | 42 | 7.9 % | 8.1 % | 2.90 | — | 0.0 | — | — | — | — | -2.6 | — | — | 0.0 % | -168.0 % | -95.1 % | — | — | +1,992.8 % | 3 | 0.0 % | 0.0 % | -46.4 | 46.0 % | 4.1 % | 4.6 (7) |
| FEAM 5E Advanced Materials Inc | — | -33 % | ⚠ Wildest 10% 113 % | Stage 4 | D 36 | 4 of 9 | 0.1 $ | Specialty Chemicals | – | — | — | Basic Materials | 2.10 $ | -50.8 % | -59.3 % | -48.4 % | −82.5 % | +108.3 % | 7 | 42 | 8.4 % | 8.8 % | 1.98 | — | 0.0 | 11.8 | 1.3 | — | — | -2.9 | — | -16,642.5 % | 0.0 % | -62.4 % | -34.6 % | 0.00 | — | -100.0 % | 2 | 0.0 % | 0.0 % | 5.4 | 69.6 % | 1.0 % | 4.0 (1) |
| SOC Sable Offshore Corp. | 08/11 | -4 % | ⚠ Wildest 10% 163 % | Stage 1 | D 44 | 3 of 9 | 0.8 $ | Oil & Gas Drilling | Neutral | — | Energy | 4.40 $ | -43.6 % | -35.9 % | -82.2 % | −82.9 % | +121.6 % | 5 | 42 | 8.8 % | 9.1 % | -0.16 | — | 5.4 | 6.1 | 1.8 | — | — | -130.8 | -9,343.4 % | -128.2 % | 0.0 % | -141.7 % | -14.0 % | 1.73 | 30.7 % | — | — | 0.0 % | 0.0 % | -1.8 | 79.5 % | 30.3 % | 4.8 (5) | |
| HUMA Humacyte Inc | 08/10 | -26 % | ⚠ Wildest 10% 115 % | Stage 4 | D 37 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 0.5751 $ | -27.1 % | -26.0 % | -62.4 % | −78.2 % | +224.6 % | 5 | 42 | 14.9 % | 12.7 % | 2.45 | — | 35.8 | 71.4 | 14.8 | — | — | 4.3 | — | -3,742.3 % | 0.0 % | -409.5 % | -49.9 % | 5.67 | — | -100.0 % | 3 | 0.0 % | 0.0 % | -21.1 | 22.3 % | 10.8 % | 4.6 (7) |
| BYND Beyond Meat Inc | 08/05 | -33 % | ⚠ Wildest 10% 191 % | Stage 4 | C 48 | 3 of 9 | 0.2 $ | Packaged Foods | Neutral | — | Consumer Defensive | 11.70 $ | -22.7 % | -13.5 % | -85.7 % | −82.5 % | +21.4 % | 5 | 42 | 6.9 % | 6.9 % | 2.76 | — | 5,000.0 | 0.7 | 1,125.3 | — | 40.75 | 1.2 | -69.3 % | 10.3 % | 115.9 % | -1,167.0 % | -15.5 % | — | 0.0 % | -15.6 % | 2 | 0.0 % | 0.0 % | -2.3 | 32.7 % | 27.5 % | 2.2 (10) | |
| CRDF Cardiff Oncology Inc | 08/04 | -5 % | ⚠ Wildest 10% 92 % | Stage 4 | D 35 | 3 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.30 $ | -55.5 % | -60.1 % | -35.3 % | −73.5 % | +277.4 % | 5 | 42 | 10.3 % | 10.0 % | 1.46 | — | 0.0 | 247.5 | 2.6 | — | — | -3.7 | — | -6,854.5 % | 0.0 % | -84.8 % | -46.7 % | 0.02 | — | -13.2 % | 5 | 0.0 % | 0.0 % | -25.3 | 32.8 % | 15.3 % | 4.7 (7) |
| INO Inovio Pharmaceuticals Inc | 08/11 | -26 % | ⚠ Wildest 10% 95 % | Stage 4 | C 47 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | -35.1 % | -50.2 % | -44.5 % | −63.8 % | +163.9 % | 5 | 42 | 4.8 % | 6.5 % | 1.63 | — | 16.6 | — | 16.3 | — | — | -1.1 | — | — | 0.0 % | -296.4 % | -84.2 % | 1.43 | — | -70.0 % | 4 | 0.0 % | 0.0 % | -128.0 | 47.3 % | 20.7 % | 4.0 (5) |
| SRFM Surf Air Mobility Inc. | 08/11 | — | ⚠ Wildest 10% 99 % | Stage 4 | D 38 | 4 of 9 | 0.1 $ | Airlines | – | — | — | Industrials | 0.635 $ | -45.9 % | -56.3 % | -85.1 % | −90.8 % | +891.1 % | 5 | 42 | 12.5 % | 9.2 % | 2.82 | — | 0.0 | 0.6 | 1.6 | — | — | -0.6 | — | 1.6 % | -101.6 % | 0.0 % | -34.5 % | -1.60 | — | -10.8 % | 4 | 0.0 % | 0.0 % | -29.5 | 19.1 % | 13.1 % | 3.7 (3) |
| TNXP Tonix Pharmaceuticals Holding Corp | 08/10 | -33 % | 70 % | Stage 4 | C 51 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 11.40 $ | -23.4 % | -24.1 % | -58.8 % | −82.9 % | +277.1 % | 5 | 42 | 7.9 % | 8.3 % | 1.75 | — | 0.0 | 6.2 | 0.9 | — | — | 0.9 | — | 83.8 % | 0.0 % | -72.3 % | -46.8 % | 0.01 | — | +29.9 % | 4 | 0.0 % | 0.0 % | 0.4 | 45.6 % | 18.1 % | 5.0 (2) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The working version of our own analysis of 792 U.S. bankruptcies since 2005. Its core finding: no single warning sign carries a verdict — even the sharpest one is wrong in more than 95 out of 100 cases. Only accumulation matters. With no signal active, 0.18 percent of companies filed for bankruptcy within twelve months; with six active at once, 3.16 percent did.
All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 138 stocks pass this scanner's criteria (as of September 18, 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Parabolic Death Cross
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.